There are no classic withdrawal effects in the way we think of for drugs like steroids, opioids, or benzodiazepines when voriconazole is stopped. However, some patients do experience transient symptoms or rebound effects, especially if the drug was managing an active infection or inflammation.
Here’s what you should know:
✅ What Usually Happens When Voriconazole Is Stopped?
1. No physiological withdrawal syndrome
-
Voriconazole does not cause dependence or withdrawal at a chemical level.
-
You don’t need to taper it for pharmacological reasons — it can generally be stopped abruptly.
⚠️ But Some Symptoms May Still Appear
These aren’t “withdrawal” symptoms in the classical sense, but can occur:
A. Return of underlying symptoms
-
If the aspergillosis was only partially controlled, symptoms like cough, chest pain, or fatigue may recur.
-
Especially in CPA or ABPA, stopping antifungals too soon can cause flare-ups.
B. Immune rebound
-
Very rarely, immune reconstitution reactions (like in ABPA or after neutropenia) may occur as the immune system re-engages with fungal antigens.
-
This is not true withdrawal, but a host response shift.
C. Psychological or sensory changes
-
Some patients who had visual disturbances or strange dreams while on voriconazole report a brief “readjustment” period after stopping (often relief, but occasionally some lingering discomfort).
-
These effects usually resolve quickly.
👩⚕️ What To Watch For After Stopping
| Symptom | Likely Cause | What to Do |
|---|---|---|
| Return of cough, sputum, fatigue | Infection flaring again | Recheck IgE, CRP, imaging, sputum |
| Headache, dizziness | Rarely linked to stopping, more likely underlying illness or fatigue | Monitor; seek review if worsening |
| Mood shifts, anxiety | Possibly related to underlying illness stress, or stopping long-term meds | Supportive care, discuss with clinician |
🧾 Summary
-
No true withdrawal syndrome with voriconazole
-
Symptoms that return are usually related to underlying disease or immune changes
-
Best to stop under specialist advice, ideally with a plan for monitoring over 2–6 weeks
Share this post
Latest News posts
🩺 Article 1: Colonisation vs Infection in Airways Disease
October 30, 2025
Living with Primary Ciliary Dyskinesia (PCD) and Bronchiectasis
October 30, 2025
🏠 Awaab’s Law: What It Means for Social Housing Tenants
October 27, 2025
🧠 Can Aspergillosis Spread to the Brain?
October 24, 2025
🌧️ Damp Homes and Aspergillosis: Why This Matters
October 23, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
